Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase...

Full description

Bibliographic Details
Main Authors: Yu, Yu, Gaillard, S., Phillip, J., Huang, T., Pinto, S., Tessarollo, N., Zhang, Z., Pandey, A., Wirtz, D., Ayhan, A., Davidson, B., Wang, T., Shih, I.
Format: Journal Article
Published: 2015
Online Access:http://hdl.handle.net/20.500.11937/21755